精确控制药物释放在机器学习设计的抗体选植入物中,用于对玻璃眼瘤的术后痕抑制
Mengqi Qin1, Wenbing Jiang1, Kai Xin Thong1
1Faculty of Life Sciences and Medicine, King's College London, London, UK.
Advanced healthcare materials
|January 22, 2026
概括
我们创建了一个智能植入物,用于持续的药物输送,使用机器学习来预测释放. 这种新的系统在临床前模型中有效减少纤维化,显示伤口愈合和预防术后痕的前景.
科学领域:
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
- 眼科医生 眼科 眼科
背景情况:
- 手术后纤维化和痕形成是一个重大的临床挑战.
- 持续提供抗纤维菌剂对于有效治疗至关重要.
- 目前的药物递送方法往往缺乏对释放动力学的精确控制.
研究的目的:
- 开发一种智能,可扩展的副结膜植入物,用于持续输送基本纤维细胞生长因子单克隆抗体 (FGFb mAb).
- 利用机器学习精确预测和控制药物释放概况.
- 在临床前模型中评估开发的植入系统的疗效和生物相容性.
主要方法:
- 制造聚烯 (PCL) 和聚乙烯糖醇 (PEG) 微圆柱体植入物.
- 机器学习 (LightGBM) 分析以根据制造参数预测药物释放动力学.
- 在体外评估纤维细胞介导的原体收缩和纤维细胞基因表达.
- 在大鼠绿眼镜过手术 (GFS) 模型中的体内研究与组织学分析.
主要成果:
- 轻GBM准确地预测了药物释放动力学 (R2 = 0.9000 ± 0.0058).
- 使用PLGA生物涂层的优化PCL-PEG植入物显示持续的抗体释放.
- 在体外和体外的研究表明,纤维化标志物和原体收缩的显著抑制.
- 植入系统没有显著的毒性和良好的生物相容性.
结论:
- 开发的智能植入系统提供精确,持续的FGFb mAb的输送,用于抗纤维化疗法.
- 机器学习集成使药物释放的准确预测和优化成为可能.
- PCL-PEG/FGFb mAb@PLGA植入物显示出调节伤口愈合和预防术后纤维化的显著潜力.
相关概念视频
PD Controller: Design
630
In automotive engineering, car suspension systems often employ Proportional Derivative (PD) controllers to enhance performance. PD controllers are utilized to adjust the damping force in response to road conditions. A controller, acting as an amplifier with a constant gain, demonstrates proportional control, with output directly mirroring input.
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
630
PI Controller: Design
1.2K
Proportional Integral (PI) controllers are a fundamental component in modern control systems, widely used to enhance performance and mitigate steady-state errors. They are particularly effective in applications such as automatic brightness adjustment on smartphones, where they excel at mitigating steady-state errors for step-function inputs. Unlike PD controllers, which require time-varying errors to function optimally, PI controllers leverage their integral component to address residual...
1.2K
Drugs Affecting Neurotransmitter Release or Uptake
1.6K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.6K
Feedback Inhibition
56.9K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
56.9K
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Glaucoma: Overview
1.3K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.3K


